The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer
N. C. Hait, D. Avni, A. Yamada, M. Nagahashi, T. Aoyagi, H. Aoki, C. I. Dumur, Z. Zelenko, E. J. Gallagher, D. Leroith, S. Milstien, K. Takabe, S. Spiegel
Research output: Contribution to journal › Article › peer-review
75Scopus
citations
Fingerprint
Dive into the research topics of 'The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer'. Together they form a unique fingerprint.